Comment on FDA approves cure for sickle cell disease, the first treatment to use CRISPR

<- View Parent
thoughtorgan@lemmy.world ⁨11⁩ ⁨months⁩ ago

It’s actually not expensive just because. They don’t manufacture this stuff in a pill packing plant with an automated machine that just churns this out.

Cell therapy takes blood from a patient and manufacturers with it to make the drug. It’s made manually by a team of people for a specific patient. The material costs alone are a quarter of the price in most cases.

Cell therapy ain’t cheap.

source
Sort:hotnewtop